This webpage contains guidance, resources, and news from around the country regarding addiction treatment in the wake of COVID-19.
Learn about how to prepare for a DEA office visit, the ASAM Standards of Care, and more.
Learn how ASAM advocates for patient privacy protections as federal regulations are changed and updated.
Learn more about the qualifications for and process to apply for a buprenorphine waiver, as well as resources ASAM has to help members increase their patient limit.
Learn more about opportunities and efforts to diversify the addiction treatment workforce.
Access information on the language of reimbursement for addiction treatment services.
ASAM provides resources to assist clinicians when dealing with payer issues.
Your source for timely, useful news briefings of top stories in addiction policy.
Subscribe to the ASAM Advocate